Characterization of salivary gland side effects secondary to 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results.

Characterization of salivary gland side effects secondary to 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. - 2013


MedStar Washington Hospital Center


Medicine/Nuclear Medicine

Powered by Koha